Autore	Bégaud Bernard
Edizione	[1st ed.]
Pubbl/distr/stampa	Chichester ; ; New York, : Wiley, c2000
Descrizione fisica	1 online resource (x, 171 p. )
Disciplina	615/.1/03
Soggetto topico	Pharmacoepidemiology Pharmacoépidémiologie Epidemiology Pharmacology Public Health Health Occupations Biological Science Disciplines Natural Science Disciplines Medicine Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology
Soggetto genere / forma	Computer network resources. Dictionary, Medical Electronic books.
ISBN	1-280-55447-9 9786610554478 0-470-85392-1 0-470-84254-7
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Record Nr.	UNINA-9910840623203321

Autore	Sneader Walter
Pubbl/distr/stampa	Chicester, : Wiley, 2005
Descrizione fisica	1 online resource (482 p.)
Disciplina	615.19 615.1909 615/.19/09
Soggetto topico	Drug development Drugs Pharmaceutical Preparations Pharmacognosy Pharmacy Pharmacy - History Drug development - History Pharmacognosy - History Humanities Chemicals and Drugs History Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology
ISBN	1-280-24171-3 0-470-01552-7
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	Drug Discovery; Contents; Preface; Foreword; Chapter 1 Introduction; PART 1 LEGACY OF THE PAST; Chapter 2 The Prehistoric Period; Chapter 3 Pre-Hellenic Civilisations; Chapter 4 Greece and Rome; Chapter 5 The Arab World; Chapter 6 Herbals; Chapter 7 Chemical Medicines; Chapter 8 Systematic Medicine; PART 2 DRUGS FROM NATURALLY OCCURRING PROTOTYPES; SECTION I PHYTOCHEMICALS; Chapter 9 Alkaloids; Chapter 10 Non-Alkaloidal Plant Products; Chapter 11 Plant Product Analogues and Compounds Derived from Them; SECTION II BIOCHEMICALS; Chapter 12 The Origins of Hormone Therapy Chapter 13 NeurohormonesChapter 14 Peptide Hormones; Chapter 15 Sex Hormones; Chapter 16 Adrenal Cortex Hormones; Chapter 17 Prostaglandins; Chapter 18 Hormone Analogues; Chapter 19 Vitamins; Chapter 20 Antimetabolites; Chapter 21 Blood and Biological Products; SECTION III DRUGS FROM MICRO-ORGANISMS; Chapter 22 Antibiotics; Chapter 23 Antibiotic Analogues; Chapter 24 Pharmacodynamic Agents from Micro-organisms; Chapter 25 Analogues of Pharmacodynamic Agents from Fungi; PART 3 SYNTHETIC DRUGS; Chapter 26 The First Synthetic Drugs and Their Analogues Chapter 27 Drugs Originating from the Screening of DyesChapter 28 Drugs Originating from the Screening of Organic Chemicals; Chapter 29 Drugs Discovered through Serendipitous Observations Involving Humans; Chapter 30 Drugs Discovered through Serendipity in the Laboratory; Chapter 31 Concluding Remarks; Index
Record Nr.	UNINA-9910161659803321

Pubbl/distr/stampa	[Place of publication not identified], : Wiley VCH, 2001
Descrizione fisica	1 online resource (406 pages)
Disciplina	615/.7
Collana	Methods and principles in medicinal chemistry Drug targeting
Soggetto topico	Drug targeting Drug Delivery Systems Drug Therapy Therapeutics Analytical, Diagnostic and Therapeutic Techniques and Equipment Pharmacy, Therapeutics, & Pharmacology Health & Biological Sciences
Soggetto genere / forma	Electronic books.
ISBN	1-280-64441-9 9786610644414 3-527-60006-X
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Record Nr.	UNINA-9910146052003321

Autore	Wills Simon
Edizione	[2nd ed.]
Pubbl/distr/stampa	[Place of publication not identified], : Pharmaceutical Press, 2005
Descrizione fisica	1 online resource (416 pages)
Disciplina	615/.78
Soggetto topico	Drugs of abuse Pharmaceutical Preparations Diseases Mental Disorders Substance-Related Disorders Street Drugs Psychiatry and Psychology Chemicals and Drugs Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology
ISBN	0-85711-117-5
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	Cover -- Prelims -- Contents -- Preface -- Acknowledgements -- About the author -- Chapter 1 - Introduction -- The global problem -- Concepts -- Withdrawing drugs in dependence -- Methods of administration -- Drug abuse environments -- Legalisation -- References -- Chapter 2 - Injection of drugs -- Infection -- Irritant effects -- Emboli, blood vessel occlusion and thrombosis -- Pharmacological effects -- 'Stigmata' -- References -- Chapter 3 - Opioids -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Opioid dependence -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 4 - Cannabis -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Abuse and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 5 - Cocaine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 6 - Amfetamine, metamfetamine, ecstasy and related drugs -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Other amfetamine derivatives -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 7 - LSD -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Abuse and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 8 - Gamma hydroxybutyrate -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology. Adverse effects -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 9 - Phencyclidine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- References -- Chapter 10 - Volatile substance abuse -- History -- Effects sought -- Administration -- Pharmacokinetics -- Adverse effects -- Long-term use -- Pregnancy and breastfeeding -- Reducing the abuse problem -- References -- Chapter 11 - Performance-enhancing drugs -- Anabolic-androgenic steroids -- Androgenic-anabolic steroid precursors -- Analgesics -- Beta-blockers -- Clenbuterol -- Diltiazem -- Diuretics -- Erythropoietin -- Nutritional supplements -- References -- Chapter 12 - Prescription drugs -- Anaesthetics -- Antidepressants -- Antimuscarinic drugs -- Sedatives -- Other drugs -- References -- Chapter 13 - Over-the-counter products -- Extent of the problem -- Sympathomimetics -- Dextromethorphan -- Opioid-containing preparations -- Analgesics -- Antihistamines -- Laxatives -- Miscellaneous OTC preparations -- Illicit drug manufacture -- Controlling the problem -- References -- Chapter 14 - Caffeine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Caffeine dependence and withdrawal -- Interaction with medicines -- Pregnancy and breastfeeding -- References -- Chapter 15 - Tobacco -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Interaction with medicines -- Pregnancy and breastfeeding -- References -- Chapter 16 - Alcohol -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Alcohol withdrawal -- Maintaining abstinence -- Interactions with medicines -- Pregnancy and breastfeeding -- References. Chapter 17 - Plants and fungi -- Ayahuasca -- Betel -- Caffeine-containing plants -- Ephedra -- Ginseng -- Kava -- Khat -- Morning glory -- Mushrooms -- Nutmeg -- Peyote cactus -- Potato family -- Salvia divinorum -- Yohimbe -- References -- Chapter 18 - Alkyl nitrites -- History -- Administration -- Effects sought -- Adverse effects -- Drug interactions -- Pregnancy and breastfeeding -- References -- Chapter 19 - Smart drugs -- Abuse liability -- Availability -- Development of smart drugs -- Claims made for smart drugs -- Modes of action -- Future use of smart drugs -- References -- Chapter 20 - Substance misuse and the Internet -- General websites -- Specific topics -- User-oriented sites -- References -- Appendix A - Glossary of street terminology -- Appendix B - Legal status of drugs in the UK -- 1. Misuse of Drugs Act (1971) -- 2. Misuse of Drugs Regulations (updated 2001) -- Drugs not covered -- Index.
Record Nr.	UNINA-9910164945703321